Compound ID | 877
Class: Fluoroquinolone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Effective dosage in mice models were lower than those of ofloxacin, ciprofloxacin and tosufloxacin against S. epidermidis 1392, S. pyogenes 1412 and S. pneumoniae 2132. |
| Description: | Biedenbach DJ, Sutton LD and Jones RN. Antimicrobial activity of CS-940, a new trifluorinated quinolone. Antimicrobial Agents and Chemotherapy. 1995;39(10):2325. |
| Institute where first reported: | Sankyo Co., Japan, Ube Industries, Japan |
| Year first mentioned: | 1993 |
| Highest developmental phase: | Phase 2 |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9889840 |
| Citation: |